p16阳性与阴性口咽癌放化疗后治疗失败模式差异
这项多中心回顾性分析纳入674例AJCC第七版III-IVa/b期口咽癌患者,均接受根治性IMRT±全身治疗。p16阳性肿瘤远处复发更多见(尤其重度吸烟者),p16阴性以局部区域失败为主;p16阳性者DFS、OS及复发后生存均显著更优。
要点
- p16阳性口咽癌远处复发比例更高,重度吸烟者尤甚。
- p16阴性口咽癌以局部区域治疗失败为主。
- p16阳性者DFS、OS及复发后生存均显著优于p16阴性者。
核心结论
- 口咽癌复发模式随HPV状态和吸烟史不同而异。
- p16阳性重度吸烟者远处转移增多且生存较差,属独立高危亚组。
- 仅凭p16状态不足以完成风险分层,需结合吸烟史细化。
研究设计与样本
- 回顾性多中心分析,纳入674例AJCC第七版III-IVa/b期口咽癌患者。
- 患者来自14个南欧中心,均接受根治性IMRT±全身治疗。
- 比较p16分组及吸烟类别间的复发模式、DFS、OS和复发后生存。
主要发现
- p16阳性肿瘤远处复发发生率更高,重度吸烟者中尤为明显。
- p16阴性口咽癌以局部区域失败为主。
- p16阳性患者DFS、OS及复发后生存均显著优于p16阴性患者。
临床怎么用
- 对p16阳性口咽癌患者应关注远处转移风险,尤其重度吸烟者。
- 对p16阴性患者应重点加强局部区域控制。
- 风险分层除p16状态外应纳入吸烟史,以识别高危亚组。
局限性
- 回顾性设计可能引入选择偏倚。
- 采用AJCC第七版分期,非当前版本。
- 摘要未报告具体数值、置信区间及P值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oropharyngeal cancer (OPC) exhibits distinct clinical behaviors according to HPV/p16 status and smoking exposure. While HPV-positive OPC generally shows superior survival, differences in recurrence patterns remain unclear. METHODS: A retrospective multicenter analysis of 674 AJCC VII edition Stage III-IVa/b OPC patients treated with definitive IMRT ± systemic therapy was conducted across 14 Southern European centers. Recurrence patterns, disease-free survival (DFS), overall survival (OS), and survival after recurrence (rOS) were compared between p16 groups and across smoking categories. RESULTS: HPV-positive tumors showed a higher incidence of distant recurrence, particularly among heavy smokers, while p16-negative OPC displayed predominantly locoregional failure. p16-positive patients had significantly better DFS, OS, and rOS. CONCLUSION: Recurrence patterns in OPC differ by HPV status and smoking history. HPV-positive heavy smokers represent a distinct high-risk subgroup characterized by increased distant metastasis and inferior survival, warranting refined stratification beyond p16 status alone.
引用
- Gili R, Bossi P, Lalli L, et al. Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal Carcinoma. Head Neck. 2026. PMID: 41786623. doi:10.1002/hed.70222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。